BSEOthers25 Aug 2026 · 25 Aug 2026, 05:44 pm
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the ....
Lactose India Ltd · 524202
✦ AI SummaryMgmt Change
Lactose India Ltd has announced the outcome of its Board Meeting held on 25th August 2026, where the Board approved various items including re-appointment of internal auditors, cost auditors, and other matters.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lactose India Ltd - 524202 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 25Th August 2026
Attachments (1)
📄pdf
Download →
1dbf9750-3343-4f02-aea8-f734e610d73f.pdf
View document text
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai‐ 400001
Scrip Code: 524202
Subject: Outcome of the Board Meeting of the company held on 25th August 2026
Dear Sir,
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the Board of
Directors of the Company at their meeting held on Tuesday, 25th August 2026 at 04.00 P.M. has, inter
alia, considered and approved the following:
1. Approval for Director’s Report for the financial year 2025‐2026.
2. Draft Notice convening 35th Annual General Meeting of the Company through electronic mode
[video conferencing (“VC”) or any other audio‐visual means (“OAVM”)];
3. Re‐appointment of Director who is retiring by rotation;
4. Approve the remuneration of Mr. Atul Maheshwari, Managing Director of the Company.
5. Approve the remuneration of Mrs. Sangita Maheshwari, Whole Time Director of the Company.
6. Approval of Secretarial Audit Report for the FY 2025‐26.
7. Approval of Internal Audit Report for the FY 2025‐26.
8. Approval of Internal Audit Report for the First Quarter Ended as on 30th June, 2026.
9. Approval of Cost Audit Report for the FY 2025‐26.
10. Appointment of Internal Auditors for the FY 2026‐27. The brief information as required under
Regulation 30 of the SEBI Listing Regulations, read with Circular No. HO/49/14/14(7)2025‐CFD‐
POD2/I/3762/2026 dated January 30, 2026, enclosed herewith as Annexure A.
11. Noting of Resignation of M/s. Kirit Mehta & Co., Cost Accountants) as Cost Auditors of the
company.
12. Appointment of Cost Auditors for the FY 2026‐27. The brief information as required under
Regulation 30 of the SEBI Listing Regulations, read with Circular No. HO/49/14/14(7)2025‐CFD‐
POD2/I/3762/2026 dated January 30, 2026, enclosed herewith as “Annexure B”.
13. Appointment of M/s. Jajodia & Associates, Practising Company Secretary as a Scrutinizer for the
upcoming AGM.
14. Approval of Related Party Transactions.
15. Appointment of Bigshare Services Private Limited for E‐voting facility for Annual General Meeting;
The Meeting of the Board of Directors of the Company was commenced at 04.00 A.M. and concluded
at 05:00 P.M.
We request you to take the above information on record.
Thanking you,
FOR LACTOSE (INDIA) LIMITED
RITESH PANDEY
Company Secretary
Mem No. A45942
Date: 25th August, 2026
Place: Mumbai
Annexure A
1. RE‐APPOINTMENT OF M/S. AMS & Co. CHARTERED ACCOUNTANTS AS INTERNAL AUDITORS OF
THE COMPANY:
We wish to inform you that the Board of Directors in their meeting held on 25th August, 2026
have considered and approved the re‐appointment of M/S. AMS & Co. Chartered Accountants as
internal auditors of the company for the Financial year 2026‐2027.
2. DATE OF RE‐APPOINTMENT: Tuesday, 25th August, 2026
3. DISCLOSURE OF RELATIONSHIP BETWEEN DIRECTORS: Not Applicable
4. BRIEF PROFILE: AMS & CO. was established in the year 2010 with a vision to become a “Truly
Professional Consulting Group” providing value added services and solutions with young and
dynamic leaders. We would like to introduce ourself as multi‐disciplinary Chartered Accountants
firm in the name of AMS & CO based in Mumbai rendering comprehensive range of services such
as Bank Audits, Statutory Audit, Stock Audit, Tax Audit, GST Audit, Management Compliance
Audit, and various other regular and structured advisory services and attestation functions to
more than 150 client groups. AMS & CO. is a Peer Reviewed Firm and also Empaneled with
Reserve bank of India. AMS & CO, Chartered Accountant firm is Promoted by young, aspirant and
professional Chartered Accountants having energetic approach, youthful wisdom and
experienced thought process. Our Firm focuses on providing end to end services in the
Accounting, Compliances and Financial Sector thereby providing total business solutions to our
reputed clients.
Annexure B
1. APPOINTMENT OF ALPESH A. LAKESHRI AS COST AUDITOR OF THE COMPANY:
We wish to inform you that the Board of Directors in their meeting held on 25th August, 2026
have considered and approved the Appointment of Alpesh A. Lakeshri as Cost Auditors of the
company for the Financial year 2026‐2027.
2. DATE OF APPOINTMENT: Tuesday, 25th August 2026
3. DISCLOSURE OF RELATIONSHIP BETWEEN DIRECTORS: Not Applicable
4. BRIEF PROFILE: Alpesh A. Lakeshri – qualified as a CMA in June 2022. I started my own practice in
August 2023. As a practicing Cost Accountant, I possess good amount of knowledge and
experience in the preparation of cost records and the rules and regulations of cost audits as
governed under Section 148 of the Indian Companies Act 2013.
Before founding my own firm, I spent nearly four and a half years with Kirit Mehta & Company –
Cost Accountants. During my tenure there, I supervised multiple cost audit teams and conducted
cost audits across various industries.
Throughout my practice, I have prepared cost records for various companies. Along with that I am
signing Cost Auditor for some companies:
Alivira Healthcare Private Limited
Gangwal Healthcare Private Limited
Innovation Imaging Technologies Private Limited.
Innvolution Healthcare Private Limited
J. Kumar – NCC Private Limited
Jgsonpal Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited.
Megafine Pharma (P) Limited
Piramal Pharma Limited.
SeQuent Scientific Limited
Shakti Auto Industries Private Limited